Phase II study of sequential doublets: topotecan and carboplatin, followed by paclitaxel and carboplatin, in patients with newly diagnosed advanced ovarian cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/15297200

Download in:

View as

General Info

PMID
15297200